Momordin I, an inhibitor of AP-1, suppressed osteoclastogenesis through inhibition of NF-κB and AP-1 and also reduced osteoclast activity and survival
Authors:
- 1 November 2005
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 337 (3) , 815-823
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Nuclear Factor of Activated T-cells (NFAT) Rescues Osteoclastogenesis in Precursors Lacking c-FosJournal of Biological Chemistry, 2004
- Genetic regulation of osteoclast development and functionNature Reviews Genetics, 2003
- Osteoclast differentiation and activationNature, 2003
- Phosphatidylinositol 3‐kinase coordinately activates the MEK/ERK and AKT/NFκB pathways to maintain osteoclast survivalJournal of Cellular Biochemistry, 2003
- U0126 and PD98059, Specific Inhibitors of MEK, Accelerate Differentiation of RAW264.7 Cells into Osteoclast-like CellsJournal of Biological Chemistry, 2002
- RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-βNature, 2002
- Sex Steroids and BoneRecent Progress in Hormone Research, 2002
- Therapeutic Approaches to Bone DiseasesScience, 2000
- Fosl1 is a transcriptional target of c-Fos during osteoclast differentiationNature Genetics, 2000
- Requirement for NF-κB in osteoclast and B-cell developmentGenes & Development, 1997